Detalhe da pesquisa
1.
Trastuzumab with trimodality treatment for oesophageal adenocarcinoma with HER2 overexpression (NRG Oncology/RTOG 1010): a multicentre, randomised, phase 3 trial.
Lancet Oncol
; 23(2): 259-269, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-35038433
2.
Long-term avelumab in advanced non-small-cell lung cancer: summaries and post hoc analyses from JAVELIN Solid Tumor.
Future Oncol
; 18(11): 1333-1342, 2022 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-35144482
3.
Marital Status and Overall Survival in Patients with Resectable Pancreatic Cancer: Results of an Ancillary Analysis of NRG Oncology/RTOG 9704.
Oncologist
; 25(3): e477-e483, 2020 03.
Artigo
Inglês
| MEDLINE | ID: mdl-32162826
4.
Biomarker analyses in REGARD gastric/GEJ carcinoma patients treated with VEGFR2-targeted antibody ramucirumab.
Br J Cancer
; 115(8): 974-982, 2016 10 11.
Artigo
Inglês
| MEDLINE | ID: mdl-27623234
5.
Electrocardiographic Characterization of Ramucirumab on the Corrected QT Interval in a Phase II Study of Patients With Advanced Solid Tumors.
Oncologist
; 21(4): 402-3, 2016 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-26984445
6.
Optimizing initial chemotherapy for metastatic pancreatic cancer.
Future Oncol
; 12(9): 1125-33, 2016 May.
Artigo
Inglês
| MEDLINE | ID: mdl-26939741
7.
Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial.
Lancet
; 383(9911): 31-39, 2014 Jan 04.
Artigo
Inglês
| MEDLINE | ID: mdl-24094768
8.
Overcoming resistance to programmed cell death protein 1 (PD-1) blockade with allogeneic invariant natural killer T-cells (iNKT).
Oncogene
; 43(10): 758-762, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38281989
9.
Nivolumab plus ONC201 plus in microsatellite stable (MSS) metastatic colorectal cancer (mCRC) patients: a Brown University Oncology Research Group phase Ib/II study (BrUOG379).
Transl Gastroenterol Hepatol
; 9: 15, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38716219
10.
Analysis of Radiation Therapy Quality Assurance in NRG Oncology RTOG 0848.
Int J Radiat Oncol Biol Phys
; 118(1): 107-114, 2024 Jan 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37598723
11.
Phase I Study of Elraglusib (9-ING-41), a Glycogen Synthase Kinase-3ß Inhibitor, as Monotherapy or Combined with Chemotherapy in Patients with Advanced Malignancies.
Clin Cancer Res
; 30(3): 522-531, 2024 02 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37982822
12.
Cellular immunotherapy for refractory hematological malignancies.
J Transl Med
; 11: 150, 2013 Jun 19.
Artigo
Inglês
| MEDLINE | ID: mdl-23782682
13.
Phase I study to assess the effect of adavosertib (AZD1775) on the pharmacokinetics of substrates of CYP1A2, CYP2C19, and CYP3A in patients with advanced solid tumors.
Cancer Chemother Pharmacol
; 92(3): 193-203, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37394627
14.
Adavosertib (AZD1775) does not prolong the QTc interval in patients with advanced solid tumors: a phase I open-label study.
Cancer Chemother Pharmacol
; 92(2): 141-150, 2023 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37368100
15.
Clinical features of patients with MTAP-deleted bladder cancer.
Am J Cancer Res
; 13(1): 326-339, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-36777505
16.
Tumor progression-related transmembrane protein aspartate-ß-hydroxylase is a target for immunotherapy of hepatocellular carcinoma.
J Hepatol
; 56(5): 1129-1135, 2012 May.
Artigo
Inglês
| MEDLINE | ID: mdl-22245894
17.
Objective Impact of Hematology-Oncology Hospitalist Care in an Inpatient Setting.
JCO Oncol Pract
; 18(10): e1641-e1647, 2022 10.
Artigo
Inglês
| MEDLINE | ID: mdl-35985001
18.
Malignant glioma subset from actuate 1801: Phase I/II study of 9-ING-41, GSK-3ß inhibitor, monotherapy or combined with chemotherapy for refractory malignancies.
Neurooncol Adv
; 4(1): vdac012, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35402914
19.
Clinical activity of 9-ING-41, a small molecule selective glycogen synthase kinase-3 beta (GSK-3ß) inhibitor, in refractory adult T-Cell leukemia/lymphoma.
Cancer Biol Ther
; 23(1): 417-423, 2022 12 31.
Artigo
Inglês
| MEDLINE | ID: mdl-35815408
20.
The Brown University Oncology Group Experience With FOLFOX + Nab-paclitaxel [FOLFOX-A] for Metastatic and Locally Advanced Pancreatic, BrUOG-292 and BrUOG-318.
Am J Clin Oncol
; 45(8): 327-332, 2022 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35749747